Literature DB >> 20034694

Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan.

Chia-Yen Dai1, Chi-Kung Ho, Jee-Fu Huang, Ming-Yen Hsieh, Nai-Jen Hou, Zu-Yau Lin, Shinn-Cherng Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang, Ming-Lung Yu, Wan-Long Chuang.   

Abstract

BACKGROUND & AIMS: Hepatitis C virus (HCV) infection has been shown to be associated with a low platelet count. This study aimed to elucidate the association between virologic status and platelet count in individuals with HCV infection.
METHODS: A large-scale survey, enrolling 11,239 residents, was conducted in the Kaohsiung area of Taiwan. Serum HCV RNA and non-invasive markers of fibrosis (FibroTest) were tested for antibody to HCV (anti-HCV)-positive subjects. The platelet counts of age- and sex-matched, biopsy-proven, hospital-based patients and community-based patients with minimal fibrosis were compared.
RESULTS: Anti-HCV was positive in 703 (6.2%) subjects and was significantly associated with older age, female sex, abnormal alanine aminotransferase (ALT) value and low platelet count (<150,000/microl). The independent factors significantly associated with low platelet count were abnormal ALT value (odds ratio [OR]: 3.70, 95% confidence intervals [CI]: 2.18-6.28) and positive HCV RNA (OR: 2.00, 95% CI: 1.01-3.97). After adjustment for the fibrosis, HCV RNA remained significantly associated with platelet counts.
CONCLUSIONS: Our results evaluating the association between platelet count and HCV viremia and taking the influences of fibrosis into consideration implicate that platelets may be affected directly by HCV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20034694     DOI: 10.1016/j.jhep.2009.11.017

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  23 in total

1.  Treatment uptake of patients with chronic hepatitis C: can we expect and do more?

Authors:  Chia-Yen Dai
Journal:  Dig Dis Sci       Date:  2010-12       Impact factor: 3.199

2.  Development of a novel score for early detection of hepatocellular carcinoma among high-risk hepatitis C virus patients.

Authors:  Hatem A El-mezayen; Hossam Darwish
Journal:  Tumour Biol       Date:  2014-04-01

3.  Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.

Authors:  Shawky Abdelhamid Fouad; Serag Esmat; Dalia Omran; Laila Rashid; Mohamed H Kobaisi
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

4.  Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma.

Authors:  Kiong-Ming Wong; Ming-Lun Yeh; Shih-Chung Chuang; Liang-Yen Wang; Zu-Yau Lin; Shinn-Cherng Chen; Jung-Fa Tsai; Shen-Nien Wang; Kung-Kai Kuo; Chia-Yen Dai; Ming-Lung Yu; King-The Lee; Wan-Long Chuang
Journal:  Indian J Gastroenterol       Date:  2012-08-30

5.  Novel quasi-subgenotype D2 of hepatitis B virus identified in Taiwanese aborigines.

Authors:  Huy Tran; Ming-Lung Yu; Chia-Yen Dai; I-Ling Lin; Ming-Lun Yeh; Wan-Long Chuang; Kenji Abe
Journal:  Virus Genes       Date:  2014-05-03       Impact factor: 2.332

6.  Interferon-associated hepatic steatosis is related to discrepancies in biochemical and virological responses of chronic hepatitis C to IFN-based therapy.

Authors:  Chun-Hao Chen; Jee-Fu Huang; Chung-Feng Huang; Ming-Lun Yeh; Jeng-Fu Yang; Ming-Yen Hsieh; Nai-Jen Hou; Zu-Yau Lin; Shinn-Cherng Chen; Ming-Yuh Hsieh; Liang-Yen Wang; Wan-Long Chuang; Chia-Yen Dai; Ming-Lung Yu
Journal:  Hepatol Int       Date:  2012-07-07       Impact factor: 6.047

7.  Improvement of thrombocytopenia in hepatitis C-related advanced fibrosis patients after sustained virological response.

Authors:  Kwong-Ming Kee; Jing-Houng Wang; Chao-Hung Hung; Chien-Hung Chen; Chuan-Mo Lee; Sheng-Nan Lu
Journal:  Dig Dis Sci       Date:  2012-09-22       Impact factor: 3.199

8.  Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection.

Authors:  Moutaz Derbala; Mohammed Elshiekh Elbadri; Aliaa Mohamed Amer; Saad AlKaabi; Khaleel Hassan Sultan; Yasser Medhat Kamel; Eman Hassan Satti Elsayed; Tony Yervant Avades; Prem Chandra; Fatma M Shebl
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

9.  Survival of Patients with Lung Cancer in the Setting of Liver Cirrhosis: A Multicenter Propensity Score Matching Study.

Authors:  Ming-Shian Lu; Hung-I Lu; Tzu-Ping Chen; Che-Chia Chang; Tsung-Ming Yang; Miao-Fen Chen
Journal:  Cancer Manag Res       Date:  2021-06-01       Impact factor: 3.989

10.  Effect of Direct-Acting Antiviral Therapy on Thrombocytopenic Patients with Hepatitis C Virus-Related Chronic Liver Disease.

Authors:  Mahmoud Saif-Al-Islam; Usama M Abdelaal; Mustafa Adel Younis; Hisham A Alghany Algahlan; Safaa Khalaf
Journal:  Gastroenterol Res Pract       Date:  2021-05-23       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.